pr

JAMA Cardiology : Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure

Interview with Andreas M. Zeiher, MD, author of Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure, and Peter Libby, MD, author of CHIPping Away at the Pathogenesis of Heart Failure




pr

JAMA Internal Medicine : Analysis of Proposed Medicare Reforms on Prescription Drug Total Spending and Patient Cost-Sharing

Interview with Aaron Kesselheim, author of Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs, and Francis J. Crosson, M.D., author of Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries



























pr

JAMA Cardiology : Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide












pr

JAMA Oncology : HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Interview with Nima Sharifi, M.D., author of HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer




pr

JAMA Internal Medicine : Evaluation of Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With MDROs

Interview with Christina Vandenbroucke-Grauls, MD, PhD, author of Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With Multidrug-Resistant Microorganisms: A Systematic Review and Meta-analysis, and Todd Campbell Lee, MD MPH, author of Deprescribing Proton Pump Inhibitors: Overcoming Resistance








pr

Bull Spread strategy on Tata Consumer by Nandish Shah of HDFC Securities

Primary trend of the stock is positive where stock price is trading above its 200-day SMA




pr

Tech-related firms in focus; PPFAS adds Microsoft to portfolio in April

Microsoft is one of the leaders in the cloud computing segment segment, besides Alphabet (Google) and Amazon, making the stock attractive




pr

Laurus Labs under pressure, plunges 10% after multiple block deals

Till 12:44 pm, a combined 34.4 million equity shares, representing 32.2 per cent of total equity of Laurus Labs, changed hands on the BSE and NSE.




pr

Equity flows dip 47% in Apr despite mkts seeing sharpest run-up since 2009

Debt categories continued to see redemptions. Credit risk funds saw a bulk of the outflows at Rs 19,238 crore, registering the worst month for the category in 13 months




pr

Risk-averse investors re-deploy funds in arbitrage MF schemes in April

Aversion to debt products has contributed to renewed interest in the category